Incubation of intact rat fat cells with maximally effective concentrations of insulin (1 nM, 12 min) or isoprenaline (300 nM, 3 min) increased particulate cGMP-and cilostamide-inhibited, low-Km cAMP phosphodiesterase (cAMP-PDE) activity by about 50% and 100%, respectively. In 32P-labeled cells, these agents induced serine 32P-phosphorylation of a 135-kDa particulate protein and, to a variable and lesser extent, a 44-kDa protein, which were selectively immunoprecipitated by anti-cAMP-PDE, as analyzed by SDS/ PAGE and autoradiography. In the absence of hormonal stimulation, little phosphorylation was detected (<10% of that with the hormones). The two phosphoproteins were identified as cAMP-PDE or a closely related molecule (in the case of the 44-kDa species, perhaps a proteolytic fragment) since (i) amounts of 32p in the immunoprecipitated 135-kDa protein paralleled enzyme inactivation, (ii) prior incubation of the anti-cAMP-PDE with the pure rat or bovine enzyme selectively blocked the immunoprecipitation of the phosphoproteins, (iii) 135-and 44-kDa proteins reacted with the anti-cAMP-PDE on Western immunoblots, and (iv) the two phosphoproteins copurifled with cAMP-PDE activity through DEAE-Sephacel chromatography and were isolated by highly selective affinity chromatography on cilostamide-agarose. Thus, in fat cells, catecholamine-and insulin-induced activation of the cAMP-PDE may be mediated via phosphorylation by cAMPdependent protein kinase and an insulin-activated serine protein kinase, respectively.
Although a number of cyclic nucleotide phosphodiesterases (PDEs) have been purified and extensively characterized, little is known concerning the detailed molecular mechanisms for regulation of this complex group of enzymes in intact cells (1) . One type, the membrane-associated, cGMP-and cilostamide-inhibited, low-Km cAMP phosphodiesterase (hereafter referred to as cAMP-PDE) is activated by insulin and, paradoxically, catecholamines and other agents that increase cellular cAMP in adipose tissue and liver (2) (3) (4) (5) (6) . The latter action most likely represents a feedback mechanism whereby cAMP modulates its own turnover (4, 7) . In isoprenalinestimulated rat fat cells, insulin-induced activation of cAMP-PDE seems to correlate with termination of the cAMP signal and reduction in cAMP-dependent protein kinase and thus may be important in the antilipolytic action of insulin (8) .
In both cases, hormone-induced activation of the cAMP-PDE seems to involve covalent modification of the enzyme, since the activation persists through several steps of enzyme purification (9) (10) (11) . In rat adipose tissue and human platelets, the catecholamine/cAMP-mediated activation of cAMP-PDE apparently may involve phosphorylation of the enzyme by cAMP-dependent protein kinase (12) (13) (14) (15) (16) . In this report, we demonstrate that, in isolated fat cells, both isoprenaline and insulin induce serine phosphorylation of the cAMP-PDE under conditions that activate the enzyme. From these results it may be inferred that insulin-induced activation of an unidentified serine protein kinase leads to phosphorylation/ activation of cAMP-PDE.
MATERIALS AND METHODS Materials. Specific polyclonal rabbit antibodies were raised against cAMP-PDE purified from bovine adipose tissue (17) . IgG fractions purified by chromatography on Staphylococcus aureus protein A-Sepharose CI-4B (Pharmacia) are referred to as anti-cAMP-PDE. Anti-phosphotyrosine monoclonal antibodies immobilized on Sepharose 4B were a generous gift from R. Frackelton (Brown University, Providence, RI). Formalin-fixed Staph. aureus ( tTo whom reprint requests should be addressed.
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fractions were prepared by centrifugation of the homogenate (50,000 x g, 90 min, 40C (20) . One membrane (representing one-fourth of the trichloroacetic acid precipitates) was stained for protein with Coomassie blue R250. The second membrane (representing three-fourths of the trichloroacetic acid precipitates) was utilized for immunostaining with anti-cAMP-PDE as described previously (17) . Listed are the amounts of cAMP-PDE activity and protein in the fractions used for immunoblotting.
copurified with cAMP-PDE activity (Fig. 2 (11, 17) . Both the 135-kDa and the 44-kDa (when present) 32P-labeled phosphoprotein species copurified with cAMP-PDE activity (Fig. 3A) (Fig. 2) .
All cAMP-PDE activity (as measured by its absence in the pass-through) and both phosphoproteins were adsorbed to the CIT-agarose, and they were apparently bound more tightly than the nonphosphorylated, proteolytically nicked purified PDE (11) , since they could not be eluted with 50 mM cAMP. Pure rat and bovine adipose tissue cAMP-PDE phosphorylated with the catalytic subunit of cAMP-dependent protein kinase were also adsorbed tightly to CIT-agarose and could not be eluted with 50 mM cAMP (E.D., unpublished data). A combination of cAMP and anti-cAMP-PDE released the adsorbed 135-and 44-kDa phosphoproteins, which were identified by SDS/PAGE (Fig. 3B) (Fig. 4) Copurification of cAMP-PDE activity and 135/44-kDa phosphoproteins during DEAE-Sephacel chromatography, and isolation of the phosphoproteins by subsequent CIT-agarose affinity chromatography. Detergent-solubilized particulate fractions from 32P-labeled insulinor isoprenaline-treated fat cells, obtained as in Fig. 1 , were applied to DEAE-Sephacel equilibrated in the modified solubilization buffer with reduced salt and phosphatase inhibitors, and eluted (cf. Fig. 2 ). (A) Portions were taken for assay of protein and cAMP-PDE activity (Left) and for immunoprecipitation, SDS/PAGE, and autoradiography (Right). Listed are the amount of protein and eAMP-PDE activity in the fractions: OR, original (solubilized membranes); 1, pass-through; 2, 50 mM NaBr; 3, 225 mM NaBr; 4, 450 mM NaBr. (B) In another experiment, 225 mM NaBr eluates from DEAE chromatography of samples from isoprenaline (ISO)-and insulin (INS)-treated 32P-labeled adipocytes were diluted 40-fold with 50 mM Tris HCl, pH 7.5/1 mM EDTA/5 mM MgCI2/10 ,ug of antipain per ml/10 ,ug of leupeptin per ml/10% glycerol/0.03% C13E12 and applied to a 0.3-ml CIT-agarose column (cf. refs. 11 and 17). After the pass-through, the column was washed with dilution buffer containing 2 M NaBr (6 ml) and then 100 mM NaBr (3 ml). cAMP-PDE was eluted by incubating CIT-agarose overnight with 0.5 ml of dilution buffer containing 100 mM NaBr/50 mM cAMP/60 ,ug anti-cAMP-PDE. Portions of fractions were assayed for protein and cAMP-PDE activity and subjected to immunoprecipitation, SDS/PAGE, and autoradiography. Pass-through and 2 M NaBr eluates from CIT-agarose contained neither cAMP-PDE activity nor 32p immunoprecipitated with anti-cAMP-PDE (data not shown). In cAMP and anti-cAMP-PDE eluates, cAMP-PDE was inactivated by anti-cAMP-PDE and the quantity of protein was insufficient to be measured. photyrosine exclusively (data not illustrated). The cAMP-PDE 135-and 44-kDa phosphoproteins were not adsorbed to a monoclonal anti-phosphotyrosine antibody coupled to agarose (data not shown).
DISCUSSION
This study provides strong evidence that isoprenaline and insulin induce serine phosphorylation of cAMP-PDE in fat cells under conditions in which these hormones cause activation of the enzyme, consistent with a causal relationship between phosphorylation and activation. The 32P-phosphorylated 135-and 44-kDa protein species were identified as, or closely related to, cAMP-PDE, since they were selectively immunoprecipitated by anti-cAMP-PDE (Fig. 1) and copurifled with cAMP-PDE activity (Fig. 3) . In addition, proteins of the same sizes were detected by the anti-cAMP-PDE in Western immunoblots (Fig. 2) and found to copurify with the enzyme activity.
Although the anti-cAMP-PDE selectively immunoprecipitated a predominant 135-kDa (and perhaps 44-kDa) phosphoprotein, after extensive purification from much larger amounts ofrat fat pads (11) or bovine omental fat (17) the pure cAMP-PDE exhibits a molecular mass of "100 kDa by gel chromatography and 60-to 80-kDa protein species by SDS/ PAGE. Comparable results have been reported with other analogous cGMP-inhibited cAMP-PDEs from human and bovine platelets and bovine cardiac tissue (14, 16, 22, 23) . These cGMP-inhibited cAMP-PDEs are apparently exquisitely sensitive to proteolysis during isolation, since native species in the range of 110-130 kDa can be rapidly isolated by immunoadsorption techniques, but time-consuming purification procedures, even with extensive protection from proteases, yield predominantly proteolytically nicked forms (11, 14, 16, 17, 22, 23) . Given the sensitivity of the cAMP-PDE to proteolysis, it is possible that proteolysis of the 135-kDa phosphoprotein produces the 44-kDa phosphorylated fragment and a 90-kDa nonphosphorylated, immunoreactive fragment observed in Western immunoblots of the DEAE-Sephacel fraction enriched in cAMP-PDE activity (Fig. 2) . The size difference compared to the "60-kDa species obtained in preparations from whole rat adipose tissue (11, 17) presumably reflects differences in proteases between fat cells and other cell types in adipose tissue.
The phosphorylation of the 135-kDa cAMP-PDE protein in response to isoprenaline is presumably mediated by cAMPdependent protein kinase, since the catalytic subunit of this kinase readily catalyzes the phosphorylation of the pure rat and bovine adipose tissue cAMP-PDE on a single serine residue (E.D., unpublished data). However, for technical reasons, it has not been possible to determine if the same site is phosphorylated in intact fat cells. Similar cGMP-inhibited phosphodiesterases from bovine cardiac muscle and bovine and human platelets can apparently be phosphorylated, and activated, by cAMP-dependent protein kinase in broken cell preparations (15, 16, 24) and in intact cells in response to agents which increase cAMP (14, 15, 24) . These and other (4, 7, 12, 13) data, and the present results, support the notion that cAMP modulates its own turnover by a feedback mechanism which involves activation of the cAMP-PDE through phosphorylation catalyzed by cAMP-dependent protein kinase. Fig. 1 and in Materials and Methods. The gel segment with the 135-kDa 32P-labeled phosphoprotein was cut out, the protein was electroeluted into 10 mM NH4HCO3/1 mM dithioerythritol/0.1% SDS (3 hr, 100C), dialyzed against 50 mM NH4HCO3, Iyophilized, and subjected to partial acid hydrolysis with 6 M HCI for 2 hr at 110'C. The solution was evaporated to dryness and 32P-phosphorylated amino acids were analyzed by two-dimensional thin-layer high-voltage electrophoresis in the presence of unlabeled phosphoamino acids (21) . The 32P_ phosphorylated amino acids were detected by autoradiography. PY, phosphotyrosine; PT, phosphothreonine; PS, phosphoserine.
Our results are consistent with the hypothesis that in rat fat cells insulin, by interaction with its specific cell-surface receptor and activation of receptor tyrosine kinase, increases cAMP-PDE activity by activation of a serine protein kinase responsible for phosphorylation of the particulate 135-kDa cAMP-PDE exclusively on serine residues. Several candidate intracellular serine protein kinases that are activated by insulin have recently been described (25) (26) (27) (28) . Although isoprenaline and insulin increased incorporation of 32p; into the cAMP-PDE to the same extent, isoprenaline activated the enzyme twice as much as insulin. This is consistent with phosphorylation of separate sites on the cAMP-PDE by the two hormones, as are data demonstrating that in intact adipocytes insulin and isoprenaline increase cAMP-PDE activity with different time-courses of activation, and that the two hormones, when present together, increase cAMP-PDE activity in a synergistic fashion (8) .
The number of insulin receptors in a rat fat cell that need to be activated to elicit a full metabolic response (at 1 nM insulin) can be estimated at 500-1000 (29) . The number of cAMP-PDE copies can be calculated to be only about 10-fold higher, assuming a native molecular mass of 135 kDa. This suggests a close proximity between the insulin receptor and the cAMP-PDE in an amplifying signal chain-e.g., by coupling them through the postulated serine protein kinase, itself perhaps a substrate for the insulin receptor tyrosine kinase. Clearly, the present findings and the availability of pure cAMP-PDE and its antibody provide new possibilities to examine this hypothesis experimentally.
